Abbott accused of blocking generic
Pharma Compliance Alert, March 26, 2008
Eighteen states and the District of Columbia are so sure Abbott Laboratories and Solvay's Fournier unit illegally blocked generic competition for their cholesterol medication TriCor, they're taking the companies to court.
The suit alleges Abbott and Fournier brought more than 10 sham patent-infringement lawsuits against the generic companies between 2000 and 2004, according to a press release by Iowa Attorney General Tom Miller. Abbott and Fournier either lost or dismissed all of the suits. The two companies also allegedly made minor changes to TriCor's formula to stop generic competition.
The civil lawsuit against Abbott and Fournier seeks triple the amount of damages incurred by the states' public health agencies, and also seeks damages incurred by individual consumers.
The Federal Trade Commission (FTC) filed a similar suit against Cephalon last month. In that suit, the FTC claims Cephalon made payments totaling slightly more than $200 million to four generic manufacturers so they would delay a generic drug's entry into the market until 2012.
Comments
0 comments on “Abbott accused of blocking generic ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched